HBcAg
免疫学
乙型肝炎表面抗原
抗原
乙型肝炎病毒
病毒学
NKG2D公司
免疫系统
细胞毒性T细胞
接种疫苗
乙型肝炎
医学
生物
病毒
生物化学
体外
作者
Ratna Sari Wijaya,Scott Read,Naomi R. Truong,Shuanglin Han,Dishen Chen,Haleh Shahidipour,Nicole Fewings,Stephen D. Schibeci,Mahmoud Karimi Azardaryany,Grant P. Parnell,David R. Booth,David van der Poorten,Rita Lin,Jacob George,Mark W. Douglas,Golo Ahlenstiel
出处
期刊:Gut
[BMJ]
日期:2020-03-30
卷期号:70 (2): gutjnl-2019
被引量:55
标识
DOI:10.1136/gutjnl-2019-319252
摘要
Our data support the presence of a mature mNKs following HBV antigen exposure either through vaccination or infection. Harnessing these antigen specific, functionally active mNKs provides an opportunity to develop novel treatments targeting HBV in chronic infection.
科研通智能强力驱动
Strongly Powered by AbleSci AI